Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia and Disorders With Psychotic Feature”

77 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 77 results

Testing effectiveness (Phase 2)Study completedNCT00136760
What this trial is testing

Contingent Incentives Plus Bupropion for Smoking in People With Schizophrenia

Who this might be right for
Schizophrenia and Disorders With Psychotic FeaturesTobacco Use Disorder
Brown University 57
Not applicableStudy completedNCT01866098
What this trial is testing

Naltrexone for Antipsychotic-Induced Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Yale University 144
Not applicableStudy completedNCT04874974
What this trial is testing

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+10 more
Max-Planck-Institute of Psychiatry 37
Not applicableStudy completedNCT03309475
What this trial is testing

Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind)

Who this might be right for
Schizophrenia and Disorders With Psychotic FeaturesPsychotic Episode
Instituto de Investigación Hospital Universitario La Paz 59
Testing effectiveness (Phase 2)Study completedNCT01259427
What this trial is testing

Reducing Internalized Stigma in People With Serious Mental Illness

Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+1 more
VA Office of Research and Development 252
Not applicableStudy completedNCT03434405
What this trial is testing

Mindfulness-based Social Cognition Training for Psychosis (SocialMind): A Feasibility Study

Who this might be right for
Schizophrenia and Disorders With Psychotic FeaturePsychotic Episode
Instituto de Investigación Hospital Universitario La Paz 27
Large-scale testing (Phase 3)Ended earlyNCT00637494
What this trial is testing

Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features

Who this might be right for
Psychotic DepressionSevere Major Depression With Psychotic FeaturesPsychosis
Corcept Therapeutics 292
Not applicableStudy completedNCT01597141
What this trial is testing

Psychosis: Early Detection, Intervention and Prevention

Who this might be right for
Prodromal SchizophreniaPsychotic DisordersSevere Bipolar Disorder With Psychotic Features+1 more
MaineHealth 100
Not applicableStudy completedNCT00695708
What this trial is testing

Training-induced Cerebral Reorganization in Schizophrenia

Who this might be right for
Schizophrenia
University of Konstanz 60
Not applicableStudy completedNCT00135772
What this trial is testing

Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2

Who this might be right for
Schizophrenia and Disorders With Psychotic FeaturesTobacco Use Disorder
National Institute on Drug Abuse (NIDA) 100
Testing effectiveness (Phase 2)Study completedNCT01731119
What this trial is testing

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+10 more
University of North Carolina, Chapel Hill 9
Post-approval studies (Phase 4)WithdrawnNCT00964041
What this trial is testing

Once Weekly D-cycloserine for Schizophrenia

Who this might be right for
Schizophrenia
Massachusetts General Hospital
Not applicableStudy completedNCT00980252
What this trial is testing

Medication Adherence in Schizophrenia: Development of a CBT-Based Intervention

Who this might be right for
SchizophreniaPsychotic Disorders
University of Illinois at Chicago 34
Not applicableStudy completedNCT01160679
What this trial is testing

Effectiveness of Atypical Antipsychotics on Anhedonic Features in Patients With Schizophrenia

Who this might be right for
Schizophrenia
AstraZeneca 231
Large-scale testing (Phase 3)Study completedNCT00128505
What this trial is testing

An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Major Depressive DisorderPsychotic Disorders
Corcept Therapeutics 104
Early research (Phase 1)Study completedNCT01530529
What this trial is testing

Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999

Who this might be right for
Healthy
Pfizer 12
Large-scale testing (Phase 3)Study completedNCT00130676
What this trial is testing

A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Major Depressive DisorderPsychotic Disorders
Corcept Therapeutics 257
Not applicableStudy completedNCT01995864
What this trial is testing

Critical Time Intervention-Task Shifting: Randomized Controlled Trial

Who this might be right for
SchizophreniaPsychotic Disorder
Columbia University 110
Not applicableStudy completedNCT02535923
What this trial is testing

CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes

Who this might be right for
InsomniaPsychosis
VA Office of Research and Development 47
Large-scale testing (Phase 3)Study completedNCT00208156
What this trial is testing

A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Depressive Disorder, Major
Corcept Therapeutics 87
Load More Results